MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 114 filers reported holding MACROGENICS INC in Q3 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $61,132,000 | +46.6% | 3,400,000 | +3.6% | 1.54% | +15.0% |
| Q4 2018 | $41,698,000 | -35.0% | 3,283,272 | +9.8% | 1.34% | -21.3% |
| Q3 2018 | $64,114,000 | +16.7% | 2,990,412 | +12.4% | 1.70% | +7.0% |
| Q2 2018 | $54,938,000 | -16.0% | 2,660,412 | +2.3% | 1.59% | -12.3% |
| Q1 2018 | $65,426,000 | +32.4% | 2,600,412 | 0.0% | 1.81% | +30.0% |
| Q4 2017 | $49,408,000 | +11.4% | 2,600,412 | +8.3% | 1.39% | +13.3% |
| Q3 2017 | $44,360,000 | +7.8% | 2,400,412 | +2.1% | 1.23% | -2.4% |
| Q2 2017 | $41,150,000 | -2.1% | 2,350,112 | +4.0% | 1.26% | -8.5% |
| Q1 2017 | $42,036,000 | +7.1% | 2,260,000 | +17.7% | 1.38% | -5.4% |
| Q4 2016 | $39,245,000 | -9.8% | 1,920,000 | +32.0% | 1.45% | -5.0% |
| Q3 2016 | $43,519,000 | +210.1% | 1,455,000 | +179.8% | 1.53% | +176.2% |
| Q2 2016 | $14,035,000 | – | 520,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,115,000 | $37,034,000 | 8.81% |
| INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $18,811,000 | 4.45% |
| DAFNA Capital Management LLC | 119,200 | $2,087,000 | 1.49% |
| BB BIOTECH AG | 2,350,112 | $41,150,000 | 1.26% |
| TIGER MANAGEMENT L.L.C. | 239,667 | $4,197,000 | 0.82% |
| Hood River Capital Management LLC | 576,193 | $10,089,000 | 0.70% |
| Bellevue Group AG | 316,418 | $5,540,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 175,000 | $3,064,000 | 0.44% |
| First Light Asset Management, LLC | 61,538 | $1,078,000 | 0.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 54,000 | $945,000 | 0.36% |